Altered peptide ligands and MS treatment.
Conlon
Paul
P
Steinman
Lawrence
L
D002986:Clinical Trials as Topic; D018849:Controlled Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D008024:Ligands; D015337:Multicenter Studies as Topic; D009103:Multiple Sclerosis / Q000188:drug therapy*; D010446:Peptide Fragments / Q000009:adverse effects* / Q000627:therapeutic use*
D008024:Ligands; D010446:Peptide Fragments